These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 35077583)

  • 1. Tailored risk assessment of 90-day acute heart failure readmission or all-cause death to heart failure with preserved versus reduced ejection fraction.
    Park J; Zhong X; Babaie Sarijaloo F; Wokhlu A
    Clin Cardiol; 2022 Apr; 45(4):370-378. PubMed ID: 35077583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Causes and Temporal Patterns of 30-Day Readmission Among Older Adults Hospitalized With Heart Failure With Preserved or Reduced Ejection Fraction.
    Goyal P; Loop M; Chen L; Brown TM; Durant RW; Safford MM; Levitan EB
    J Am Heart Assoc; 2018 Apr; 7(9):. PubMed ID: 29686028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The subclinical hypothyroid state might predict 30-day readmission in patients admitted with acute heart failure syndrome and reduced left ventricular ejection fraction.
    Saad M; Lacoste AG; Balar P; Zhang A; Vittorio TJ
    Ther Adv Cardiovasc Dis; 2020; 14():1753944720977742. PubMed ID: 33336627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Risk factors for rehospitalization in heart failure with preserved ejection fraction compared with reduced ejection fraction.
    Setoguchi M; Hashimoto Y; Sasaoka T; Ashikaga T; Isobe M
    Heart Vessels; 2015 Sep; 30(5):595-603. PubMed ID: 24935218
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and Outcomes of Acute Heart Failure With Preserved Versus Reduced Ejection Fraction in SPRINT.
    Upadhya B; Willard JJ; Lovato LC; Rocco MV; Lewis CE; Oparil S; Cushman WC; Bates JT; Bello NA; Aurigemma G; Johnson KC; Rodriguez CJ; Raj DS; Rastogi A; Tamariz L; Wiggers A; Kitzman DW;
    Circ Heart Fail; 2021 Dec; 14(12):e008322. PubMed ID: 34823375
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of atrial fibrillation in patients with heart failure and reduced, mid-range or preserved ejection fraction.
    Son MK; Park JJ; Lim NK; Kim WH; Choi DJ
    Heart; 2020 Aug; 106(15):1160-1168. PubMed ID: 32341140
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical characteristics of hospitalized heart failure patients with preserved, mid-range, and reduced ejection fractions in Japan.
    Shiga T; Suzuki A; Haruta S; Mori F; Ota Y; Yagi M; Oka T; Tanaka H; Murasaki S; Yamauchi T; Katoh J; Hattori H; Kikuchi N; Watanabe E; Yamada Y; Haruki S; Kogure T; Suzuki T; Uetsuka Y; Hagiwara N;
    ESC Heart Fail; 2019 Jun; 6(3):475-486. PubMed ID: 30829002
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcomes in patients with heart failure with preserved, borderline, and reduced ejection fraction in the Medicare population.
    Cheng RK; Cox M; Neely ML; Heidenreich PA; Bhatt DL; Eapen ZJ; Hernandez AF; Butler J; Yancy CW; Fonarow GC
    Am Heart J; 2014 Nov; 168(5):721-30. PubMed ID: 25440801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute heart failure with mid-range left ventricular ejection fraction: clinical profile, in-hospital management, and short-term outcome.
    Farmakis D; Simitsis P; Bistola V; Triposkiadis F; Ikonomidis I; Katsanos S; Bakosis G; Hatziagelaki E; Lekakis J; Mebazaa A; Parissis J
    Clin Res Cardiol; 2017 May; 106(5):359-368. PubMed ID: 27999929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of Diabetes Mellitus on Cardiac Remodeling, Quality of Life, and Clinical Outcomes in Heart Failure With Reduced and Preserved Ejection Fraction.
    Yap J; Tay WT; Teng TK; Anand I; Richards AM; Ling LH; MacDonald MR; Chandramouli C; Tromp J; Siswanto BB; ; Zile M; McMurray J; Lam CSP
    J Am Heart Assoc; 2019 Sep; 8(17):e013114. PubMed ID: 31431116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in cause-specific readmissions in heart failure with preserved vs. reduced and mid-range ejection fraction.
    Cui X; Thunström E; Dahlström U; Zhou J; Ge J; Fu M
    ESC Heart Fail; 2020 Oct; 7(5):2894-2903. PubMed ID: 32729678
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In-hospital and 1-year outcomes of acute heart failure patients according to presentation (de novo vs. worsening) and ejection fraction. Results from IN-HF Outcome Registry.
    Senni M; Gavazzi A; Oliva F; Mortara A; Urso R; Pozzoli M; Metra M; Lucci D; Gonzini L; Cirrincione V; Montagna L; Di Lenarda A; Maggioni AP; Tavazzi L;
    Int J Cardiol; 2014 May; 173(2):163-9. PubMed ID: 24630337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics and Clinical Outcomes in Patients With Heart Failure With Preserved Ejection Fraction Compared to Heart Failure With Reduced Ejection Fraction: Insights From the VCOR Heart Failure Snapshot.
    Tan C; Dinh D; Brennan A; Hare DL; Kaye D; Lefkovits J; Lockwood S; Neil C; Prior D; Nasis A; Wilson A; Reid CM; Stub D; Driscoll A
    Heart Lung Circ; 2022 May; 31(5):623-628. PubMed ID: 34742643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current conditions and significance of outpatient cardiac rehabilitation and home nursing-care services in heart failure patients with mid-range or preserved ejection fraction: post-hoc analysis of the REAL-HF registry.
    Kitagawa T; Hidaka T; Watanabe N; Naka M; Yamaguchi M; Kanai K; Isobe M; Kihara Y; Nakano Y;
    Heart Vessels; 2022 May; 37(5):745-754. PubMed ID: 34731295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Risk of Re-hospitalization, All-Cause Mortality, and Medical Care Resource Utilization in Patients With Heart Failure and Preserved Versus Reduced Ejection Fraction.
    Nichols GA; Reynolds K; Kimes TM; Rosales AG; Chan WW
    Am J Cardiol; 2015 Oct; 116(7):1088-92. PubMed ID: 26235928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ankle-brachial index and incident heart failure with reduced versus preserved ejection fraction: The Multi-Ethnic Study of Atherosclerosis.
    Prasada S; Shah SJ; Michos ED; Polak JF; Greenland P
    Vasc Med; 2019 Dec; 24(6):501-510. PubMed ID: 31480898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive characterization of non-cardiac comorbidities in acute heart failure: an analysis of ESC-HFA EURObservational Research Programme Heart Failure Long-Term Registry.
    Chioncel O; Benson L; Crespo-Leiro MG; Anker SD; Coats AJS; Filippatos G; McDonagh T; Margineanu C; Mebazaa A; Metra M; Piepoli MF; Adamo M; Rosano GMC; Ruschitzka F; Savarese G; Seferovic P; Volterrani M; Ferrari R; Maggioni AP; Lund LH
    Eur J Prev Cardiol; 2023 Sep; 30(13):1346-1358. PubMed ID: 37172316
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rehospitalization burden and morbidity risk in patients with heart failure with mid-range ejection fraction.
    Santas E; de la Espriella R; Palau P; Miñana G; Amiguet M; Sanchis J; Lupón J; Bayes-Genís A; Chorro FJ; Núñez Villota J
    ESC Heart Fail; 2020 Jun; 7(3):1007-1014. PubMed ID: 32212327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noncardiac Versus Cardiac Mortality in Heart Failure With Preserved, Midrange, and Reduced Ejection Fraction.
    Vergaro G; Ghionzoli N; Innocenti L; Taddei C; Giannoni A; Valleggi A; Borrelli C; Senni M; Passino C; Emdin M
    J Am Heart Assoc; 2019 Oct; 8(20):e013441. PubMed ID: 31587602
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of diabetes on mortality and rehospitalization in acute heart failure patients stratified by ejection fraction.
    Al-Jarallah M; Rajan R; Al-Zakwani I; Dashti R; Bulbanat B; Ridha M; Sulaiman K; Alsheikh-Ali AA; Panduranga P; AlHabib KF; Al Suwaidi J; Al-Mahmeed W; AlFaleh H; Elasfar A; Al-Motarreb A; Bazargani N; Asaad N; Amin H
    ESC Heart Fail; 2020 Feb; 7(1):297-305. PubMed ID: 31825180
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.